Main Menu

Pioneering technology agreement

University ties up licence deal with Merck

marc-vendrellScientists at Edinburgh university have teamed up with the life science business of health care giant Merck to develop pioneering technology in understanding how diseases progress.

Edinburgh Research & Innovation, the commercialisation arm of The University of Edinburgh, has entered a licence agreement with the company.

A research team from The University of Edinburgh’s School of Clinical Sciences, led by the Principal Investigator Dr Marc Vendrell (pictured), worked in collaboration with academic partners at the University of Barcelona and The University of Manchester on research funded by the EU Commission via a Marie Curie Career integration Grant.

Dr Angus Stewart-Liddon, ERI’s Licensing Executive, described the research as “an exciting breakthrough”

He said: “Working with the life science business of Merck means the technology will be made readily accessible to researchers worldwide, both in industry and in academia. It is another great example of the University working in collaboration with trusted industry partners to make valuable research tools accessible.”



Leave a Reply

Your email address will not be published. Required fields are marked as *

This site uses Akismet to reduce spam. Learn how your comment data is processed.